Here are the key details to know:
1. Through completion of the merger, Envision is a wholly-owned subsidiary of KKR.
2. Envision stockholders will receive $46 per share as a result of the merger.
3. The $9.9 billion acquisition was announced in June.
4. Following the acquisition, Envision (AmSurg) will have about 300 ASCs in its porfolio.
More articles on transactions and valuation:
KKR will have about 300 ASCs in its portfolio after Envision acquisition
Surgery Partners renews M&A push with plans to raise $115M — 7 insights
3 experts share their thoughts on surgery center M&A
